Home/Vor Biopharma/Jean-Paul Kress, MD
JK

Jean-Paul Kress, MD

Chief Executive Officer and Chairman

Vor Biopharma

Vor Biopharma Pipeline

DrugIndicationPhase
TelitaciceptMyasthenia Gravis (MG)Phase 3